{"DataElement":{"publicId":"6712259","version":"1","preferredName":"Programmed Cell Death 1 Ligand 1 Immunohistochemistry Staining Method Outcome Combined Positive Score","preferredDefinition":"The text response that indicates a combined positivity score in cells for the presence of the programmed cell death 1 ligand 1 protein that is encoded by the human CD274 gene observed immunohistochemical staining method techniques.","longName":"PD-L1_COMB_POS_SCR","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6053539","version":"1","preferredName":"Programmed Cell Death 1 Ligand 1 Immunohistochemistry Staining Method Outcome","preferredDefinition":"Programmed cell death 1 ligand 1 (290 aa, ~33 kDa) is encoded by the human CD274 gene. This protein is involved in the mediation of both the activation and proliferation of T cells._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._The result of an action.","longName":"6053536v1.0:6053537v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"6053536","version":"1","preferredName":"Programmed Cell Death 1 Ligand 1","preferredDefinition":"Programmed cell death 1 ligand 1 (290 aa, ~33 kDa) is encoded by the human CD274 gene. This protein is involved in the mediation of both the activation and proliferation of T cells.","longName":"C96024","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Programmed Cell Death 1 Ligand 1","conceptCode":"C96024","definition":"Programmed cell death 1 ligand 1 (290 aa, ~33 kDa) is encoded by the human CD274 gene. This protein is involved in the mediation of both the activation and proliferation of T cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"632803CA-832E-2AA6-E053-F662850A2EC4","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"ONEDATA","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6053537","version":"1","preferredName":"Immunohistochemistry Staining Method Outcome","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:The result of an action.","longName":"C23020:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"632803CA-833F-2AA6-E053-F662850A2EC4","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"ONEDATA","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"632803CA-8350-2AA6-E053-F662850A2EC4","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"GARRIDOJ","dateModified":"2018-03-01","changeDescription":"Created for EA5152, 01/19/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6712220","version":"1","preferredName":"PD-L1 Combined Positive Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"6712220v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Less than 10","valueDescription":"Less Than 10 Combined Score","ValueMeaning":{"publicId":"6712221","version":"1","preferredName":"Less Than 10 Combined Score","longName":"6712221","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::10: Made or joined or united into one or involving the joint activity of two or more.: A number or range of numeric values measuring performance, function, quality, or ability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Combined","conceptCode":"C25454","definition":"Made or joined or united into one or involving the joint activity of two or more.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8735FE12-E3F6-248E-E053-F662850AEFBA","latestVersionIndicator":"Yes","beginDate":"2019-04-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-23","modifiedBy":"ONEDATA","dateModified":"2019-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8735FE12-E40F-248E-E053-F662850AEFBA","beginDate":"2019-04-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-23","modifiedBy":"ONEDATA","dateModified":"2019-04-23","deletedIndicator":"No"},{"value":"Greater than or equal to 10","valueDescription":"Greater Than or Equal To 10 Combined Score","ValueMeaning":{"publicId":"6712222","version":"1","preferredName":"Greater Than or Equal To 10 Combined Score","longName":"6712222","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part, including the negative and positive numbers as well as zero.::10: Made or joined or united into one or involving the joint activity of two or more.: A number or range of numeric values measuring performance, function, quality, or ability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Combined","conceptCode":"C25454","definition":"Made or joined or united into one or involving the joint activity of two or more.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8735FE12-E41E-248E-E053-F662850AEFBA","latestVersionIndicator":"Yes","beginDate":"2019-04-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-23","modifiedBy":"ONEDATA","dateModified":"2019-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8735FE12-E437-248E-E053-F662850AEFBA","beginDate":"2019-04-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-23","modifiedBy":"ONEDATA","dateModified":"2019-04-23","deletedIndicator":"No"},{"value":"Not applicable for ARM A","valueDescription":"Not applicable for ARM A","ValueMeaning":{"publicId":"7070251","version":"1","preferredName":"Not applicable for ARM A","longName":"7070251","preferredDefinition":"Not applicable for ARM A","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F5CCA9-DA25-3A56-E053-F662850A705B","latestVersionIndicator":"Yes","beginDate":"2019-12-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-12-05","modifiedBy":"ONEDATA","dateModified":"2019-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"98F5CCA9-DA3E-3A56-E053-F662850A705B","beginDate":"2019-12-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-12-05","modifiedBy":"ONEDATA","dateModified":"2019-12-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2193207","version":"1","preferredName":"Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"EACFDBFA-EFD4-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8735FE12-E3DA-248E-E053-F662850AEFBA","latestVersionIndicator":"Yes","beginDate":"2019-04-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-23","modifiedBy":"SOKKERL","dateModified":"2019-12-05","changeDescription":"Curated to support EC10183","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3876594","version":"1","longName":"Theradex","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876603","version":"1","longName":"Theradex - CTMS 3.14","context":"Theradex"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"PD-L1 Status (Combined Positi","type":"Preferred Question Text","description":"PD-L1 Status (Combined Positive Score)","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"87362511-B2CB-24FC-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2019-04-23","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-23","modifiedBy":"SOKKERL","dateModified":"2019-05-15","changeDescription":"Curated to support EC10183","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}